<p><img alt="Source: IMI Innovative Medicines Initiative Annual Report 2017" data-entity-type="file" data-entity-uuid="a9875d79-b458-41d9-bcc3-005a28da0b7b" src="/sites/default/files/inline-images/84.png" /></p>

<p>Extract from IMI Innovative Medicines Initiative Annual Report 2017 (p. 166)</p>

<p>Available at:&nbsp;<a href="https://www.imi.europa.eu/sites/default/files/uploads/documents/About-IMI/Governance/Governing-Board/IMI2-GB-DEC-2018-17_Decision%20AAR%202017-GB%20Assessment_signed%2026JUN.pdf">https://www.imi.europa.eu/sites/default/files/uploads/documents/About-IMI/Governance/Governing-Board/IMI2-GB-DEC-2018-17_Decision%20AAR%202017-GB%20Assessment_signed%2026JUN.pdf</a></p>
